These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 23909638)

  • 21. Assessment of myocardial ischemia and viability using cardiac magnetic resonance.
    Bettencourt N; Chiribiri A; Schuster A; Nagel E
    Curr Heart Fail Rep; 2009 Sep; 6(3):142-53. PubMed ID: 19723455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac magnetic resonance T1 mapping. Part 2: Diagnostic potential and applications.
    Reiter U; Reiter C; Kräuter C; Fuchsjäger M; Reiter G
    Eur J Radiol; 2018 Dec; 109():235-247. PubMed ID: 30539759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relation of Myocardial Contrast-Enhanced T
    Höke U; Khidir MJ; van der Geest RJ; Schalij MJ; Bax JJ; Delgado V; Ajmone Marsan N
    Am J Cardiol; 2017 May; 119(9):1456-1462. PubMed ID: 28274575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myocardial tissue characterization by magnetic resonance imaging: novel applications of T1 and T2 mapping.
    Ferreira VM; Piechnik SK; Robson MD; Neubauer S; Karamitsos TD
    J Thorac Imaging; 2014 May; 29(3):147-54. PubMed ID: 24576837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved detection of myocardial involvement in acute inflammatory cardiomyopathies using T2 mapping.
    Thavendiranathan P; Walls M; Giri S; Verhaert D; Rajagopalan S; Moore S; Simonetti OP; Raman SV
    Circ Cardiovasc Imaging; 2012 Jan; 5(1):102-10. PubMed ID: 22038988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac magnetic resonance evaluation of myocardial viability and ischemia.
    Strzelczyk J; Attili A
    Semin Roentgenol; 2008 Jul; 43(3):193-203. PubMed ID: 18486681
    [No Abstract]   [Full Text] [Related]  

  • 27. Contrast-enhanced cardiovascular magnetic resonance imaging.
    Schneider G; Ahlhelm F; Seidel R; Fries P; Kramann B; Böhm M; Kindermann I
    Top Magn Reson Imaging; 2003 Oct; 14(5):386-402. PubMed ID: 14625467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Late gadolinium-enhancement cardiac magnetic resonance identifies postinfarction myocardial fibrosis and the border zone at the near cellular level in ex vivo rat heart.
    Schelbert EB; Hsu LY; Anderson SA; Mohanty BD; Karim SM; Kellman P; Aletras AH; Arai AE
    Circ Cardiovasc Imaging; 2010 Nov; 3(6):743-52. PubMed ID: 20847191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Late gadolinium enhancement-cardiovascular magnetic resonance as a predictor of response to cardiac resynchronization therapy in patients with ischaemic cardiomyopathy.
    Chalil S; Foley PW; Muyhaldeen SA; Patel KC; Yousef ZR; Smith RE; Frenneaux MP; Leyva F
    Europace; 2007 Nov; 9(11):1031-7. PubMed ID: 17933857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Image Quality and Reliability of a Novel Dark-Blood Late Gadolinium Enhancement Sequence in Ischemic Cardiomyopathy.
    Muscogiuri G; Gatti M; Dell'Aversana S; Guaricci AI; Guglielmo M; Baggiano A; Andreini D; Mushtaq S; Conte E; Annoni A; Formenti A; Mancini ME; Gripari P; Janich MA; Rabbat MG; Pepi M; Pontone G
    J Thorac Imaging; 2020 Sep; 35(5):326-333. PubMed ID: 32845112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue characterization of the myocardium: state of the art characterization by magnetic resonance and computed tomography imaging.
    Pattanayak P; Bleumke DA
    Radiol Clin North Am; 2015 Mar; 53(2):413-23. PubMed ID: 25727003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of Cardiac Magnetic Resonance in the Diagnosis of Infiltrative, Hypertrophic, and Arrhythmogenic Cardiomyopathies.
    Almeida PC; Lopes V; Ferreira LA; Moreira N; Marto CM; Gonçalves L; Donato P
    Front Biosci (Schol Ed); 2022 Mar; 14(1):7. PubMed ID: 35320918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Late gadolinium-enhanced cardiac magnetic resonance.
    Lin D; Kramer CM
    Curr Cardiol Rep; 2008 Feb; 10(1):72-8. PubMed ID: 18417005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of myocardial viability using MR and CT imaging.
    Krombach GA; Niendorf T; Günther RW; Mahnken AH
    Eur Radiol; 2007 Jun; 17(6):1433-44. PubMed ID: 17206427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthetic late gadolinium enhancement cardiac magnetic resonance for diagnosing myocardial scar.
    Abdula G; Nickander J; Sörensson P; Lundin M; Kellman P; Sigfridsson A; Ugander M
    Scand Cardiovasc J; 2018 Jun; 52(3):127-132. PubMed ID: 29544374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Scoring of late gadolinium enhancement in cardiac magnetic resonance imaging can predict cardiac events in patients with hypertrophic cardiomyopathy.
    Nojiri A; Hongo K; Kawai M; Komukai K; Sakuma T; Taniguchi I; Yoshimura M
    J Cardiol; 2011 Nov; 58(3):253-60. PubMed ID: 21890327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is cardiac magnetic resonance imaging assessment of myocardial viability useful for predicting which patients with impaired ventricles might benefit from revascularization?
    Child NM; Das R
    Interact Cardiovasc Thorac Surg; 2012 Apr; 14(4):395-8. PubMed ID: 22279116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. When should we use contrast material in cardiac MRI?
    Paiman EHM; Lamb HJ
    J Magn Reson Imaging; 2017 Dec; 46(6):1551-1572. PubMed ID: 28480596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Native T1-mapping for non-contrast assessment of myocardial fibrosis in patients with hypertrophic cardiomyopathy--comparison with late enhancement quantification.
    Małek ŁA; Werys K; Kłopotowski M; Śpiewak M; Miłosz-Wieczorek B; Mazurkiewicz Ł; Petryka-Mazurkiewicz J; Marczak M; Witkowski A
    Magn Reson Imaging; 2015 Jul; 33(6):718-24. PubMed ID: 25863138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Three-dimensional phase-sensitive inversion recovery sequencing in the evaluation of left ventricular myocardial scars in ischemic and non-ischemic cardiomyopathy: comparison to three-dimensional inversion recovery sequencing.
    Kido T; Kido T; Nakamura M; Kawaguchi N; Nishiyama Y; Ogimoto A; Miyagawa M; Mochizuki T
    Eur J Radiol; 2014 Dec; 83(12):2159-2166. PubMed ID: 25311877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.